{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T22:34:42Z","timestamp":1774650882926,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024075","name":"Region Syddanmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.thromres.2025.109428","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:44:41Z","timestamp":1754667881000},"page":"109428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Increased contact system activity three months after starting combined oral contraceptives"],"prefix":"10.1016","volume":"253","author":[{"given":"Jesper","family":"Strandberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette","family":"Nybo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger Lise","family":"Gade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaseelan","family":"Palarasah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Else-Marie","family":"Bladbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren Risom","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11 Pt B","key":"10.1016\/j.thromres.2025.109428_bb0005","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.bbamcr.2017.07.009","article-title":"The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity","volume":"1864","author":"Weidmann","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"5","key":"10.1016\/j.thromres.2025.109428_bb0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOH.0b013e328309ec85","article-title":"Novel roles for factor XII-driven plasma contact activation system","volume":"15","author":"M\u00fcller","year":"2008","journal-title":"Curr. Opin. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1040-8428(86)80053-1","article-title":"The contact activation system: biochemistry and interactions of these surface-mediated defense reactions","volume":"5","author":"Colman","year":"1986","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"8","key":"10.1016\/j.thromres.2025.109428_bb0020","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood.2019002224","article-title":"Protease activity in single-chain prekallikrein","volume":"135","author":"Ivanov","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109428_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1067\/mai.2002.121316","article-title":"Pathways for bradykinin formation and inflammatory disease","volume":"109","author":"Kaplan","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.thromres.2025.109428_bb0035","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.biomaterials.2008.12.041","article-title":"Contact activation of blood-plasma coagulation","volume":"30","author":"Vogler","year":"2009","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.thromres.2025.109428_bb0040","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.bbagen.2015.03.005","article-title":"C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: implication for a role in hereditary angioedema","volume":"1850","author":"Madsen","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.thromres.2025.109428_bb0045","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-0036-1598003","article-title":"Factor XII contact activation","volume":"43","author":"Naudin","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109428_bb0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-0031-1276586","article-title":"The plasma contact system 2.0","volume":"37","author":"Maas","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109428_bb0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jth.15149","article-title":"Proteolytic activity of contact factor zymogens","volume":"19","author":"Shamanaev","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"15","key":"10.1016\/j.thromres.2025.109428_bb0060","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.clinbiochem.2016.06.011","article-title":"Calibrated kallikrein generation in human plasma","volume":"49","author":"Biltoft","year":"2016","journal-title":"Clin. Biochem."},{"issue":"11","key":"10.1016\/j.thromres.2025.109428_bb0065","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2016-10-744110","article-title":"Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation","volume":"129","author":"Ivanov","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","author":"Medicine, P.C.o.t.A.S.f.R","year":"2017","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0075","first-page":"1","article-title":"The risk of venous thromboembolism with different generation of oral contraceptives; a systematic review and meta-analysis","volume":"2","author":"Baratloo","year":"2014","journal-title":"Emerg (Tehran)"},{"key":"10.1016\/j.thromres.2025.109428_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.thromres.2025.109428_bb0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archinte.167.3.282","article-title":"Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study","volume":"167","author":"van Vlijmen","year":"2007","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2025.109428_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.thromres.2025.109428_bb0100","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1365-2141.2001.02853.x","article-title":"Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over","volume":"113","author":"Mackie","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109428_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1542\/peds.2010-2221","article-title":"Hormonal contraception and thrombotic risk: a multidisciplinary approach","volume":"127","author":"Trenor","year":"2011","journal-title":"Pediatrics"},{"issue":"4 Pt 2","key":"10.1016\/j.thromres.2025.109428_bb0110","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0002-9378(87)80129-1","article-title":"Coagulation effects of oral contraception","volume":"157","author":"Bonnar","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.thromres.2025.109428_bb0115","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","article-title":"Increased thrombin generation in women with polycystic ovary syndrome: a pilot study on the effect of metformin and oral contraceptives","volume":"64","author":"Glintborg","year":"2015","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.thromres.2025.109428_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100118","article-title":"Combined oral contraceptives may activate the contact system in healthy women","volume":"7","author":"Strandberg","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"17","key":"10.1016\/j.thromres.2025.109428_bb0125","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0130","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1038\/s41467-021-25888-7","article-title":"Identification of the factor XII contact activation site enables sensitive coagulation diagnostics","volume":"12","author":"Heestermans","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.thromres.2025.109428_bb0135","first-page":"69","article-title":"Development of new anticoagulant in 2023: prime time for anti-factor XI and XIa inhibitors","volume":"48","author":"Bentounes","year":"2023","journal-title":"J Med Vasc"},{"issue":"5","key":"10.1016\/j.thromres.2025.109428_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOH.0b013e3283497e61","article-title":"Factor XI and XII as antithrombotic targets","volume":"18","author":"M\u00fcller","year":"2011","journal-title":"Curr. Opin. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109428_bb0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MOH.0000000000000603","article-title":"The rebirth of the contact pathway: a new therapeutic target","volume":"27","author":"Srivastava","year":"2020","journal-title":"Curr. Opin. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109428_bb0150","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jtha.2023.03.024","article-title":"High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism","volume":"21","author":"Grover","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109428_bb0155","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1055\/s-0039-1678737","article-title":"Plasma concentrations of high molecular weight kininogen and prekallikrein and venous thromboembolism incidence in the general population","volume":"119","author":"Folsom","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2025.109428_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jim.2013.04.012","article-title":"ELISA for determination of total coagulation factor XII concentration in human plasma","volume":"394","author":"Madsen","year":"2013","journal-title":"J. Immunol. Methods"},{"issue":"10","key":"10.1016\/j.thromres.2025.109428_bb0165","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1055\/a-1346-3384","article-title":"Effect of anabolic-androgenic steroid abuse on the contact activation system","volume":"121","author":"Sidelmann","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109428_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.873975","article-title":"Plasma kallikrein cleaved H-kininogen: an end-point marker for contact activation in vitro and ex vivo","volume":"9","author":"Palarasah","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.thromres.2025.109428_bb0180","series-title":"K.S. Power Calculations","author":"Gupta","year":"2025"},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12959-025-00713-z","article-title":"The effect of combined oral contraceptives on thrombin generation assessed on ST Genesia\u2013 a paired clinical study","volume":"23","author":"Strandberg","year":"2025","journal-title":"Thromb. J."},{"issue":"24","key":"10.1016\/j.thromres.2025.109428_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413370","article-title":"High molecular weight kininogen: a review of the structural literature","volume":"22","author":"Ponczek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1471-0528.1993.tb12956.x","article-title":"Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill","volume":"100","author":"Campbell","year":"1993","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109428_bb0200","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1055\/s-0038-1657871","article-title":"Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen\u2014levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator","volume":"54","author":"Jespersen","year":"1985","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109428_bb0205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0049-3848(94)90268-2","article-title":"Contact factors in plasma from women on oral contraception\u2014significance of factor XI for the measured activity of factor XII","volume":"74","author":"Fossum","year":"1994","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109428_bb0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0049-3848(91)90343-U","article-title":"Contact activation factors in plasma from women using oral contraceptives\u2014increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein","volume":"64","author":"Hoem","year":"1991","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109428_bb0215","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/1047-2797(92)90093-6","article-title":"Estrogen-associated thromboembolism","volume":"2","author":"Wessler","year":"1992","journal-title":"Ann. Epidemiol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109428_bb0220","first-page":"762","article-title":"Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives","volume":"96","author":"Gordon","year":"1980","journal-title":"J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1515\/cclm-2023-0384","article-title":"The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review","volume":"62","author":"\u00d6zcan","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.thromres.2025.109428_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.761255","article-title":"The pathological mechanisms of estrogen-induced cholestasis: current perspectives","volume":"12","author":"Zu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109428_bb0235","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad079","article-title":"Estrogen and the vascular endothelium: the unanswered questions","volume":"164","author":"SenthilKumar","year":"2023","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.thromres.2025.109428_bb0240","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1073\/pnas.97.11.5930","article-title":"Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling","volume":"97","author":"Russell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.thromres.2025.109428_bb0245","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1055\/s-0038-1648985","article-title":"Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives","volume":"72","author":"Norris","year":"1994","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2025.109428_bb0250","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2009.11.001","article-title":"Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo","volume":"139","author":"M\u00fcller","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.thromres.2025.109428_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12654","article-title":"Thrombin generation measured on ST Genesia, a new platform in the coagulation routine lab: assessment of analytical and between-subject variation","volume":"6","author":"Kristensen","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"22","key":"10.1016\/j.thromres.2025.109428_bb0260","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","article-title":"In vivo roles of factor XII","volume":"120","author":"Renn\u00e9","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2025.109428_bb0265","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00281-021-00876-7","article-title":"The contact system in liver injury","volume":"43","author":"Rangaswamy","year":"2021","journal-title":"Semin. Immunopathol."},{"issue":"22","key":"10.1016\/j.thromres.2025.109428_bb0270","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1182\/bloodadvances.2021005116","article-title":"Polyphosphate expression by cancer cell extracellular vesicles mediates binding of factor XII and contact activation","volume":"5","author":"Shim","year":"2021","journal-title":"Blood Adv."},{"issue":"11","key":"10.1016\/j.thromres.2025.109428_bb0275","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood-2015-01-622811","article-title":"The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis","volume":"126","author":"Nickel","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109428_bb0280","first-page":"9","article-title":"Recent advances in understanding, diagnosing and treating venous thrombosis","author":"Chan","year":"2020","journal-title":"F1000Res"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2025.109428_bb0285","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0049-3848(10)70147-X","article-title":"Factor Xa and thrombin as targets for new oral anticoagulants","volume":"127","author":"Weitz","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109428_bb0290","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.thromres.2023.07.007","article-title":"Estimation of the preanalytical activation of the contact system in coagulation tubes","volume":"229","author":"Kristensen","year":"2023","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:27:31Z","timestamp":1761406051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825001781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"alternative-id":["S0049384825001781"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109428","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased contact system activity three months after starting combined oral contraceptives","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109428"}}